Education
About Us
Working with TipRanks
Follow Us
Lifeward (LFWD)
NASDAQ:LFWD
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.27Last Year’s EPS
-0.5Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 15, 2025
|% Change Since: -12.50%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
While Lifeward faced challenges such as revenue decline and supply constraints, significant progress was made in strategic partnerships, product approvals, and operational efficiencies. This suggests a positive outlook for the company's future performance.Company Guidance
During the Q1 2025 earnings call, Lifeward Inc. provided detailed guidance, emphasizing several key metrics. The company reported Q1 revenues of $5 million, down from $5.3 million in Q1 2024 due to a $500,000 catch-up revenue from Medicare in the previous year. Despite this, Lifeward highlighted significant operational progress, including over 120 qualified ReWalk leads in the US, a 70% increase over two quarters, and 36 ReWalk rentals, primarily in Germany, indicating future sales. AlterG sales grew by 19% and 17% in the last two quarters. The company achieved a 25% reduction in Q1 operating loss and expects further reductions as savings phase in. GAAP gross margin rose to 42.2% from 26.4% in Q1 2024, while operating expenses decreased to $7 million from $7.9 million. Lifeward reaffirmed its 2025 sales guidance between $28 million to $30 million, anticipating a Q4 adjusted operating loss of approximately $1 million.FDA Clearance of ReWalk 7
Lifeward received FDA clearance for the ReWalk 7, the next generation exoskeleton, marking significant progress in their product offerings.
Partnership with CorLife
Lifeward entered into a partnership with CorLife to improve access in the workers' compensation segment, aiming to drive profitable growth.
Expansion in Germany
The ReWalk contract with BARMER in Germany was expanded, potentially setting a model for working with other insurers in the region.
Increase in Qualified ReWalk Leads
The pipeline of qualified ReWalk leads in the US increased by over 70% in the past two quarters.
AlterG Product Growth
AlterG products grew by 19% and 17% in the last two quarters, with a strong first quarter performance driven by international sales.
Reduction in Operating Loss
Lifeward achieved a 25% reduction in operating loss in Q1, with expectations for further reductions as revenue grows.
LFWD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LFWD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 15, 2025 | $1.44 | $1.29 | -10.42% |
Mar 07, 2025 | $1.58 | $1.63 | +3.16% |
Nov 12, 2024 | $2.37 | $2.39 | +0.84% |
Aug 15, 2024 | $3.12 | $4.07 | +30.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lifeward (LFWD) report earnings?
Lifeward (LFWD) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Lifeward (LFWD) earnings time?
Lifeward (LFWD) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFWD EPS forecast?
LFWD EPS forecast for the fiscal quarter 2025 (Q2) is -0.27.